| http://www.w3.org/ns/prov#value | - The deal is an expansion of an existing partnership between Evotec and the Harvard lab of Douglas Melton known as the CureBeta research and development program, created to better identify and develop targets that could cause the regeneration of insulin-producing beta cells in people with diabetes.
|
